Docoh
Loading...

PAVM PAVmed

News

From Benzinga Pro
61 Biggest Movers From Yesterday
18 Nov 21
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers Sono Group N.V. (NASDAQ: SEV) shares climbed 154.7% to close at $38.20 on Wednesday after the company priced its IPO at $15 per share.
12 Health Care Stocks Moving In Wednesday's Intraday Session
17 Nov 21
Movers
Gainers
42 Stocks Moving In Wednesday's Mid-Day Session
17 Nov 21
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Gainers Sono Group N.V. (NASDAQ: SEV) shares jumped 66% to $24.90 after the company priced its IPO at $15 per share.
Mid-Morning Market Update: Markets Down; Lowe's Earnings Beat Estimates
17 Nov 21
Earnings, News, Penny Stocks, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets
Following the market opening Wednesday, the Dow traded down 0.34% to 36,017.63 while the NASDAQ fell 0.19% to 15,944.13. The S&P also fell, dropping 0.23% to 4,690.06.
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
17 Nov 21
Pre-Market Outlook, Markets, Movers
The Daily Biotech Pulse: Kezar Jumps On Data, Biogen R&D Chief To Retire, Molecular Partners Wilts On COVID Trial Disappointment
16 Nov 21
Biotech, Earnings, News, Penny Stocks, Offerings, Small Cap, General
Here's a roundup of top developments in the biotech space over the last 24 hours:
Earnings Scheduled For November 16, 2021
16 Nov 21
Earnings, News, Pre-Market Outlook, Markets
Companies Reporting Before The Bell • Ozon Holdings (NASDAQ:OZON) is expected to report quarterly loss at $0.90 per share on revenue of $602.00 million.
The Week Ahead In Biotech (Nov. 14-Nov. 20): BioMarin FDA Decision, Tapering Earnings News Flow, Conference Presentations And More
14 Nov 21
Biotech, Earnings, News, Penny Stocks, Small Cap, FDA, Top Stories
Biotech stocks declined for the second straight week amid a broader market pullback, along with earnings news from small- and micro-cap companies and presentations at multiple conferences.
PAVmed Subsidiary Lucid Diagnostics Launches Next Phase of Lucid Test Centers
11 Nov 21
News
rapid, non-invasive, office-based test to detect esophageal precancer before it progresses to deadly esophageal cancer Lucid Diagnostics Inc. (NASDAQ:LUCD) ("Lucid") a commercial-stage, cancer prevention
12 Health Care Stocks Moving In Wednesday's After-Market Session
27 Oct 21
Movers
Gainers
44 Biggest Movers From Yesterday
15 Oct 21
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers Benessere Capital Acquisition Corp. (NASDAQ: BENER) shares jumped 66.5% to close at $0.4530 on Thursday.
12 Health Care Stocks Moving In Thursday's Intraday Session
14 Oct 21
Movers
Gainers
The Daily Biotech Pulse: Moderna Awaits Adcom Ruling On COVID-19 Booster Shot; Teligent Files For Chapter 11; CFO Transitions at Catalyst Biosciences, CRISPR; Lucid Diagnostics Debuts
14 Oct 21
Biotech, News, Penny Stocks, Guidance, Small Cap, FDA, IPOs, General
Here's a roundup of top developments in the biotech space over the last 24 hours:
The Week Ahead In Biotech (Oct. 10-16): Avadel FDA Decision, Conference Presentations And IPOs Take Center Stage
10 Oct 21
Biotech, Earnings, News, FDA, IPOs
Biotech stocks retreated in the week ending Oct. 8, extending losses for the third straight week. Some of the selling in the space was due to money moving out of defensive stocks and into risky bets amid the broader market strength.
PAVmed Acquires EsophaCap Manufacturer CapNostics; Terms Not Disclosed
7 Oct 21
M&A
PAVmed Inc. (NASDAQ:PAVM, PAVMZ)))) (the "Company" or "PAVmed"), a highly differentiated, multi-product, commercial-stage medical technology company, today announced a wholly owned subsidiary of
58 Biggest Movers From Yesterday
24 Sep 21
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) shares surged 73.4% to close at $12.80 on Thursday following news the company will buy ZACC Kabushiki Kaisha for $3.362 million.
Why PAVmed Shares Are Trading Higher Today
23 Sep 21
News, Small Cap, IPOs
PAVmed Inc (NASDAQ: PAVM) is trading higher Thursday after the company announced its majority-owned subsidiary, Lucid Diagnostics, filed a registration statement for a proposed initial public offering.
12 Health Care Stocks Moving In Thursday's Intraday Session
23 Sep 21
Intraday Update, Markets, Movers
PAVmed's Subsidiary, Lucid Diagnostics Files For $58M IPO
23 Sep 21
Long Ideas, News, Health Care, Financing, Offerings, Small Cap, IPOs, Movers, Trading Ideas, General
Lucid Diagnostic, a maker of diagnostic tests for esophageal precancer and cancer, filed to raise up to $58 million in an IPO.
38 Stocks Moving In Thursday's Mid-Day Session
23 Sep 21
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Gainers MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) shares jumped 101% to $14.87 following news the company will buy ZACC Kabushiki Kaisha for $3.362 million.

Press releases

From Benzinga Pro
22nd Century Group Announces CFO Transition
19 Nov 21
News, Management, Press Releases
Richard Fitzgerald Joins as Chief Financial Officer John Franzino Transitions to Chief Administrative Officer BUFFALO, N.Y., Nov. 19, 2021 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NASDAQ:XXII), a leading
Lucid Diagnostics to Present at Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services Forum
17 Nov 21
Press Releases
Lucid Diagnostics Inc. (NASDAQ:LUCD) ("Lucid") a commercial-stage, cancer prevention medical diagnostics company, and majority-owned subsidiary of PAVmed Inc. (NASDAQ:PAVM, PAVMZ)) ("PAVmed"), today announced that
PAVmed and Lucid Provide Business Update and Preliminary Third Quarter 2021 Financial Results
16 Nov 21
Press Releases
Conference call to be held today at 4:30 PM EDT PAVmed Inc. (NASDAQ:PAVM, PAVMZ)) ("PAVmed"), a highly differentiated, multi-product, commercial-stage medical device company, and its majority-owned subsidiary Lucid
PAVmed Subsidiary Lucid Diagnostics Launches Next Phase of Lucid Test Centers
11 Nov 21
Press Releases
Patients in Denver, Salt Lake City, and Las Vegas metropolitan areas now have access to a rapid, non-invasive, office-based test to detect esophageal precancer before it progresses to deadly esophageal cancer Lucid
PAVmed and Lucid to Hold Joint Business Update Conference Call on November 16, 2021
3 Nov 21
Press Releases
Company conference call and webcast at 4:30PM EDT PAVmed Inc. (NASDAQ:PAVM, PAVMZ)), a highly differentiated, multi-product, commercial-stage medical device company, and its major subsidiary Lucid Diagnostics Inc.
Veris Health Showcased in PAVmed Digital Health Virtual Investor Event
29 Oct 21
Press Releases
Panelists discussed Veris' vision and strategy to transform cancer care and join the current digital health revolution PAVmed Inc. (NASDAQ:PAVM, PAVMZ)) (the "Company" or "PAVmed"), a highly differentiated,
Lucid Diagnostics' EsoGuard Esophageal DNA Test Wins "Diagnostics Innovation of the Year" Award
28 Oct 21
Press Releases
BioTech Breakthrough's Annual Awards Program Recognizes Innovation in the Global Life Sciences and Biotechnology Industry Lucid Diagnostics Inc. (NASDAQ:LUCD) ("Lucid") a commercial-stage, cancer prevention medical
PAVmed Digital Health Subsidiary Veris Health Appoints Sunny Webb as Chief Technology Officer
25 Oct 21
Press Releases
PAVmed Inc. (NASDAQ:PAVM, PAVMZ)) ("PAVmed"), a highly differentiated, multi-product, commercial-stage medical technology company, and its digital health subsidiary Veris Health ("Veris") today announced the appointment
Lucid Diagnostics Appoints Suman Verma MD, PhD as Chief Scientific Officer
21 Oct 21
Press Releases
Lucid Diagnostics Inc. (NASDAQ:LUCD) ("Lucid") a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (NASDAQ:PAVM, PAVMZ)) ("PAVmed"), today announced the appointment of highly
Lucid Diagnostics Announces Closing of Nasdaq Initial Public Offering
18 Oct 21
Press Releases
Lucid Diagnostics Inc. (NASDAQ:LUCD) ("Lucid") a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (NASDAQ:PAVM, PAVMZ)) ("PAVmed"), today announced the closing on October
Lucid Diagnostics Announces Pricing of Initial Public Offering
13 Oct 21
Press Releases
NEW YORK, Oct. 13, 2021 (GLOBE NEWSWIRE) -- Lucid Diagnostics Inc. (NASDAQ:LUCD) ("Lucid") a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (NASDAQ:PAVM, PAVMZ))
PAVmed Acquires EsophaCap Manufacturer CapNostics LLC
7 Oct 21
Press Releases
NEW YORK, Oct. 07, 2021 (GLOBE NEWSWIRE) -- PAVmed Inc. (NASDAQ:PAVM, PAVMZ)) (the "Company" or "PAVmed"), a highly differentiated, multi-product, commercial-stage medical technology company, today announced a wholly
PAVmed to Host Digital Health Virtual Investor Event
30 Sep 21
Press Releases
Veris Health: Bringing Digital Health to Cancer Care October 26, 2021, from 1 p.m. to 3 p.m. EDT PAVmed Inc. (NASDAQ:PAVM, PAVMZ)) (the "Company" or "PAVmed"), a highly differentiated, multi-product, commercial-stage
PAVmed Subsidiary, Lucid Diagnostics, Files Registration Statement for Proposed Initial Public Offering
23 Sep 21
Press Releases
PAVmed Inc. (NASDAQ:PAVM, PAVMZ)) ("PAVmed"), a highly differentiated, multi-product, commercial-stage medical technology company, and its majority-owned subsidiary, Lucid Diagnostics Inc. ("Lucid"), announced yesterday
Thinking about buying stock in Matinas BioPharma, BlackBerry, Sundial Growers, PAVmed, or Orchard Therapeutics?
23 Sep 21
Opinion, Press Releases
NEW YORK, Sept. 23, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for MTNB, BB, SNDL, PAVM, and ORTX.
PAVmed Subsidiary Veris Health Joins Microsoft for Startups Global Program and Engages Loka as Software Development Partner
21 Sep 21
Press Releases
Veris remote digital healthcare platform to utilize first intelligent implantable vascular access port with biologic sensors and wireless communication to improve cancer care PAVmed Inc. (NASDAQ:PAVM, PAVMZ)) (the
Demand Continues to Grow for Crucial Medical Supplies
16 Sep 21
Small Cap, Opinion, Press Releases
NEW YORK, Sept. 16, 2021 /PRNewswire/ -- The emergence of the pandemic has helped accelerate the growth of demand for diagnostic supplies such as ventilators, N95 masks, and PPE kits, which in turn is fueling the medical
PAVmed to Participate in September Investor and MedTech Conferences
7 Sep 21
Press Releases
Presentations scheduled at Lake Street Capital Markets BIG5, Cantor Fitzgerald Virtual Global Healthcare, and The MedTech Conference PAVmed Inc. (NASDAQ:PAVM, PAVMZ)) (the "Company" or "PAVmed"), a highly